Definitive Contract 75F40121C00093
- Not listed
- This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for $2,538,816.41 and provides office support services to the FDA's Office of Clinical Policy. The contract is a Delivery Order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and...
- This is a $2,469,135.04 definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, an 8(a) certified Small Disadvantaged Business. The contract is for facilitation and coordination support services for IT initiatives, including regulatory review and production support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), support for the Center for Drug Evaluation and Research (CDER),...
- This is a Firm Fixed Price delivery order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business registered to receive federal contract awards since 2014. The objective of this order is to acquire expert consulting support and services to support the mission of the FDA's Office of Business Informatics (OBI). Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB), will provide operational and...
- This is a sole source 8(a) set-aside federal contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small, minority-owned, woman-owned business. The contract is for $597,096.99 and provides process documentation and development services to the FDA's Center for Drug Evaluation and Research (CDER). The contract has a period of performance through August 21, 2028. Agisol LLC, a certified 8(a) program participant, is the prime contractor for this contract. The company...
- The Food and Drug Administration (FDA) awarded a definitive firm fixed-price contract to Agisol LLC, a small, minority-owned, woman-owned business based in Marriottsville, Maryland, on July 30, 2024, with a ceiling value of $750,814.42. This Competitive 8(a) set-aside contract supports the FDA's personal property management and fleet management programs by delivering analytics, metrics, training, quality assurance, and property management information system (PMIS) services. Work will be...
- The U.S. Food and Drug Administration (FDA) awarded a $1,189,125.49 time-and-materials contract to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to streamline processes and enhance new drug review services. This contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions. Agisol LLC specializes in providing IT services and solutions...
- This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services...
- The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the...
- This is a labor-hour award made by the U.S. Food and Drug Administration (FDA) to Agisol LLC, an 8(a) certified small disadvantaged business, to provide regulatory review of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) production support services for the Center for Drug Evaluation and Research (CDER). The contract, valued at $4,499,636.43, runs from the award date of February 4, 2024 through December 17, 2025. Agisol LLC has extensive experience supporting the FDA's...
- The Department of Health and Human Services Food and Drug Administration awarded a $3.8 million definitive contract to Agisol LLC of Silver Spring, Maryland. The contract is for the DOCUMENT ARCHIVING, REPORTING, AND REGULATORY TRACKING SYSTEM and has a period of performance from January 21, 2022 to January 17, 2024. The pricing structure is firm fixed price. The contract was set aside for 8(a) Sole Source small businesses. Agisol LLC will provide document archiving, reporting, and regulatory...
Agisol LLC, an 8(a) certified Economically Disadvantaged Small Woman Owned business, has been awarded a $855,193.20 definitive contract by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to streamline processes and enhance new drug review under an 8(a) sole source set aside designation. The contract has a completion date of September 25, 2022 and pricing is set as time and materials. Agisol LLC will draw from its experience providing IT services and solutions to HHS FDA, including facilitating coordination for IT initiatives and document archiving to support the agency's new drug review, drug safety, and other regulatory programs. As the prime contractor, Agisol LLC aims to optimize FDA workflows through this contract. Additionally, Agisol LLC maintains position on the 8(a) STARS III GWAC, a multiple award IDIQ vehicle through which it has received over $3.6 million in delivery orders from HHS FDA for related services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 11/17/21 | |
| Not listed | Not listed | $855.2k | 8/18/21 |